Literature DB >> 730362

Suppression of cellular immune responses in guinea pigs infected with spotted fever group rickettsiae.

C N Oster, R H Kenyon, C E Pedersen.   

Abstract

Using a guinea pig model, we demonstrated that infections with pathogenic species of spotted fever group rickettsiae transiently and nonspecifically suppress established cellular immune responses as measured by in vitro lymphocyte transformation and in vivo delayed cutaneous hypersensitivity responses to unrelated, nonrickettsial antigens. The correlation of the duration of this immunosuppression with the virulence of the infecting rickettsial species suggests that this suppression is a pathological effect of the rickettsial infection. Although we did not specifically study the mechanism of this suppression, it is not associated with either lymphocytopenia or leukocytosis.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 730362      PMCID: PMC422171          DOI: 10.1128/iai.22.2.411-417.1978

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  29 in total

1.  THE ROCKY MOUNTAIN SPOTTED FEVER GROUP OF RICKETTSIAS.

Authors:  D B LACKMAN; E J BELL; H G STOENNER; E G PICKENS
Journal:  Health Lab Sci       Date:  1965-07

2.  Immunosuppression in man: suppression by macrophages can be mediated by interactions with regulatory T cells.

Authors:  J D Stobo
Journal:  J Immunol       Date:  1977-09       Impact factor: 5.422

3.  Cell-mediated immune responses in humans after induced infection with influenza A virus.

Authors:  R Dolin; D D Richman; B R Murphy; A S Fauci
Journal:  J Infect Dis       Date:  1977-05       Impact factor: 5.226

Review 4.  Humoral factors influencing lymphocyte transformation.

Authors:  D S Nelson; R A Gatti
Journal:  Prog Allergy       Date:  1976

5.  Laboratory-acquired Rocky Mountain spotted fever. The hazard of aerosol transmission.

Authors:  C N Oster; D S Burke; R H Kenyon; M S Ascher; P Harber; C E Pedersen
Journal:  N Engl J Med       Date:  1977-10-20       Impact factor: 91.245

6.  Specific suppression of the immune response by a factor obtained from spleen cells of mice tolerant to human gamma-globulin.

Authors:  M Taniguchi; J F Miller
Journal:  J Immunol       Date:  1978-01       Impact factor: 5.422

7.  Splenic role in the regulation of immune responses.

Authors:  C G Romball; W O Weigle
Journal:  Cell Immunol       Date:  1977-12       Impact factor: 4.868

8.  Inhibition of tuberculin-induced mitogenesis in cultures of lymphocytes from tuberculous donors.

Authors:  D H Heilman; W McFarland
Journal:  Int Arch Allergy Appl Immunol       Date:  1966

9.  The evolution of immunosuppressive cell populations in experimental mycobacterial infection.

Authors:  W E Bullock; E M Carlson; R K Gershon
Journal:  J Immunol       Date:  1978-05       Impact factor: 5.422

10.  In vitro guinea pig leukocyte reactions to Rickettsia rickettsii.

Authors:  R H Kenyon; M S Ascher; R A Kishimoto; C E Pedersen
Journal:  Infect Immun       Date:  1977-12       Impact factor: 3.441

View more
  4 in total

1.  Rocky Mountain spotted fever vaccine in an animal model.

Authors:  J D Folds; D H Walker; B C Hegarty; D Banasiak; J V Lange
Journal:  J Clin Microbiol       Date:  1983-08       Impact factor: 5.948

2.  Cross-reactive lymphocyte responses and protective immunity against other spotted fever group rickettsiae in mice immunized with Rickettsia conorii.

Authors:  T R Jerrells; D L Jarboe; C S Eisemann
Journal:  Infect Immun       Date:  1986-03       Impact factor: 3.441

3.  Suppression of in vitro lymphocyte proliferation in C57BL/10 ScN mice vaccinated with phase I Coxiella burnetii.

Authors:  T A Damrow; J C Williams; D M Waag
Journal:  Infect Immun       Date:  1985-01       Impact factor: 3.441

4.  Symbiotic immuno-suppression: is disease susceptibility the price of bleaching resistance?

Authors:  Daniel G Merselis; Diego Lirman; Mauricio Rodriguez-Lanetty
Journal:  PeerJ       Date:  2018-04-17       Impact factor: 2.984

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.